• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏磁共振在非缺血性心肌病的诊断和预后中的作用。

Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy.

机构信息

Department of Medicine and Radiology, University of Chicago, Chicago, Illinois.

Departments of Medicine and Radiology and the Cardiovascular Imaging Center, University of Virginia Health System, Charlottesville, Virginia.

出版信息

JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt A):1180-1193. doi: 10.1016/j.jcmg.2017.08.005.

DOI:10.1016/j.jcmg.2017.08.005
PMID:28982571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5708889/
Abstract

Cardiac magnetic resonance (CMR) is a valuable tool for the evaluation of patients with, or at risk for, heart failure and has a growing impact on diagnosis, clinical management, and decision making. Through its ability to characterize the myocardium by using multiple different imaging parameters, it provides insight into the etiology of the underlying heart failure and its prognosis. CMR is widely accepted as the reference standard for quantifying chamber size and ejection fraction. Additionally, tissue characterization techniques such as late gadolinium enhancement (LGE) and other quantitative parameters such as T mapping, both native and with measurement of extracellular volume fraction; T mapping; and T* mapping have been validated against histological findings in a wide range of clinical scenarios. In particular, the pattern of LGE in the myocardium can help determine the underlying etiology of the heart failure. The presence and extent of LGE determine prognosis in many of the nonischemic cardiomyopathies. The use of CMR should increase as its utility in characterization and assessment of prognosis in cardiomyopathies is increasingly recognized.

摘要

心脏磁共振(CMR)是评估心力衰竭患者或有心力衰竭风险患者的一种有价值的工具,它对诊断、临床管理和决策制定的影响越来越大。通过使用多种不同的成像参数来对心肌进行特征描述,CMR 可以深入了解心力衰竭的潜在病因及其预后。CMR 被广泛接受为量化心室大小和射血分数的参考标准。此外,组织特征描述技术,如延迟钆增强(LGE)和其他定量参数,如 T 映射,无论是原生的还是测量细胞外容积分数的;T 映射;以及 T*映射已经在广泛的临床情况下通过与组织学发现进行验证。特别是,心肌中 LGE 的模式可以帮助确定心力衰竭的潜在病因。在许多非缺血性心肌病中,LGE 的存在和程度决定了预后。随着 CMR 在心肌病的特征描述和预后评估中的应用越来越多,其使用也应增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f71/5708889/3df2a81d1998/nihms900410f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f71/5708889/1f9b26fd63e3/nihms900410f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f71/5708889/5cb3fbcfc73a/nihms900410f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f71/5708889/b5161aff8f1f/nihms900410f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f71/5708889/005b6e6b6c42/nihms900410f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f71/5708889/7b3b7b7babb0/nihms900410f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f71/5708889/3df2a81d1998/nihms900410f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f71/5708889/1f9b26fd63e3/nihms900410f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f71/5708889/5cb3fbcfc73a/nihms900410f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f71/5708889/b5161aff8f1f/nihms900410f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f71/5708889/005b6e6b6c42/nihms900410f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f71/5708889/7b3b7b7babb0/nihms900410f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f71/5708889/3df2a81d1998/nihms900410f6.jpg

相似文献

1
Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy.心脏磁共振在非缺血性心肌病的诊断和预后中的作用。
JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt A):1180-1193. doi: 10.1016/j.jcmg.2017.08.005.
2
Contemporary Application of Cardiovascular Magnetic Resonance Imaging.心血管磁共振成像的当代应用。
Annu Rev Med. 2020 Jan 27;71:221-234. doi: 10.1146/annurev-med-041818-015923.
3
Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis.心脏磁共振晚期钆增强在系统性淀粉样变中的预后价值。
JACC Cardiovasc Imaging. 2016 Nov;9(11):1267-1277. doi: 10.1016/j.jcmg.2016.01.036. Epub 2016 Aug 24.
4
Comparison of quantitative imaging parameters using cardiovascular magnetic resonance between cardiac amyloidosis and hypertrophic cardiomyopathy: inversion time scout versus T1 mapping.利用心血管磁共振成像对心脏淀粉样变性和肥厚型心肌病的定量成像参数进行比较:反转时间预扫描与T1映射。
Int J Cardiovasc Imaging. 2018 Nov;34(11):1769-1777. doi: 10.1007/s10554-018-1385-2. Epub 2018 May 30.
5
Cardiac magnetic resonance in hypertrophic and dilated cardiomyopathies.肥厚型和扩张型心肌病的心脏磁共振成像。
Radiol Med. 2020 Nov;125(11):1056-1071. doi: 10.1007/s11547-020-01276-x. Epub 2020 Sep 18.
6
Role of Cardiac MR Imaging in Cardiomyopathies.心脏磁共振成像在心肌病中的作用。
J Nucl Med. 2015 Jun;56 Suppl 4(0 4):39S-45S. doi: 10.2967/jnumed.114.142729.
7
Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis.心脏结节病患者心肌瘢痕在心脏磁共振成像中的预后价值
JACC Cardiovasc Imaging. 2017 Apr;10(4):411-420. doi: 10.1016/j.jcmg.2016.05.009. Epub 2016 Jul 20.
8
Cardiovascular magnetic resonance for suspected cardiac amyloidosis: where are we now?疑似心脏淀粉样变性的心血管磁共振:我们现在在哪里?
Heart Fail Rev. 2022 Sep;27(5):1543-1548. doi: 10.1007/s10741-022-10226-w. Epub 2022 Mar 4.
9
Cardiac magnetic resonance imaging as a prognostic tool in patients with nonischemic cardiomyopathy.心脏磁共振成像作为非缺血性心肌病患者的预后评估工具
Hosp Pract (1995). 2010 Nov;38(4):75-82. doi: 10.3810/hp.2010.11.343.
10
3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.3.0 T磁共振心肌灌注成像用于肥厚型心肌病冠状动脉微血管功能障碍的半定量评估
Int J Cardiovasc Imaging. 2017 Dec;33(12):1949-1959. doi: 10.1007/s10554-017-1189-9. Epub 2017 Jun 13.

引用本文的文献

1
Dual-energy based myocardial extracellular volume quantification with photon-counting detector and energy-integrating detector dual-source computed tomography: comparison with cardiac magnetic resonance.基于双能量的心肌细胞外容积定量分析:采用光子计数探测器和能量积分探测器双源计算机断层扫描与心脏磁共振成像的比较
Eur Radiol. 2025 Sep 3. doi: 10.1007/s00330-025-11942-1.
2
Serial cardiac magnetic resonance imaging to assess myocardial inflammation in PET-positive cardiac sarcoidosis under immunomodulatory therapy: a retrospective observational study.采用连续心脏磁共振成像评估免疫调节治疗下PET阳性心脏结节病的心肌炎症:一项回顾性观察研究。
BMJ Open. 2025 Aug 25;15(8):e098540. doi: 10.1136/bmjopen-2024-098540.
3

本文引用的文献

1
Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction.扩张型心肌病伴轻中度左心室收缩功能障碍患者中壁晚期钆增强与心源性猝死的关联
Circulation. 2017 May 30;135(22):2106-2115. doi: 10.1161/CIRCULATIONAHA.116.026910. Epub 2017 Mar 28.
2
Long-Term Prognostic Value of Cardiac Magnetic Resonance in Left Ventricle Noncompaction: A Prospective Multicenter Study.左心室心肌致密化不全的心脏磁共振长期预后价值:一项前瞻性多中心研究。
J Am Coll Cardiol. 2016 Nov 15;68(20):2166-2181. doi: 10.1016/j.jacc.2016.08.053.
3
Myocardial Perfusion Imaging with Cardiovascular Magnetic Resonance in Nonischemic Cardiomyopathies: An In-Depth Review of Techniques and Clinical Applications.
非缺血性心肌病的心血管磁共振心肌灌注成像:技术与临床应用的深入综述
Medicina (Kaunas). 2025 May 10;61(5):875. doi: 10.3390/medicina61050875.
4
Editorial: Pre-interventional cardiac imaging.社论:介入前心脏成像
Front Cardiovasc Med. 2025 Apr 23;12:1605768. doi: 10.3389/fcvm.2025.1605768. eCollection 2025.
5
The value of left ventricular T1 mapping and left atrial strain for distinguishing myocardial amyloidosis and hypertrophic cardiomyopathy.左心室T1映射和左心房应变在鉴别心肌淀粉样变性和肥厚型心肌病中的价值。
Int J Cardiovasc Imaging. 2025 Jul;41(7):1277-1286. doi: 10.1007/s10554-025-03410-0. Epub 2025 Apr 29.
6
Late Gadolinium Enhancement of Nonischemic Cardiomyopathy at 5.0 T versus 3.0 T: A Crossover Design Study.5.0T与3.0T场强下非缺血性心肌病的延迟钆增强:一项交叉设计研究
Radiol Cardiothorac Imaging. 2024 Dec;6(6):e240035. doi: 10.1148/ryct.240035.
7
Advances in Cardiac Imaging and Genetic Testing for Diagnosis and Risk Stratification in Cardiomyopathies: 2024 Update.心肌病诊断与风险分层的心脏成像和基因检测进展:2024年更新
J Clin Med. 2024 Nov 26;13(23):7166. doi: 10.3390/jcm13237166.
8
Atrial fibrillation ablation: The key ingredient for managing arrhythmia-induced cardiomyopathy.心房颤动消融术:治疗心律失常性心肌病的关键要素。
HeartRhythm Case Rep. 2024 Nov 15;10(11):773-774. doi: 10.1016/j.hrcr.2024.08.030. eCollection 2024 Nov.
9
Biventricular longitudinal strain analysis using cardiovascular magnetic resonance feature-tracking: Prognostic value in Eisenmenger syndrome.使用心血管磁共振特征追踪的双心室纵向应变分析:艾森曼格综合征的预后价值。
J Cardiovasc Magn Reson. 2024;26(2):101116. doi: 10.1016/j.jocmr.2024.101116. Epub 2024 Oct 28.
10
Alteration of cardiac structure and function and its prognostic value in patients with Takayasu arteritis: a cardiac magnetic resonance study.大动脉炎患者心脏结构和功能改变及其预后价值:一项心脏磁共振研究
Front Cardiovasc Med. 2024 Sep 19;11:1475535. doi: 10.3389/fcvm.2024.1475535. eCollection 2024.
Left Ventricular Noncompaction: Anatomical Phenotype or Distinct Cardiomyopathy?
左心室心肌致密化不全:解剖学表型还是独特的心肌病?
J Am Coll Cardiol. 2016 Nov 15;68(20):2157-2165. doi: 10.1016/j.jacc.2016.08.054.
4
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.非缺血性收缩性心力衰竭患者的除颤器植入
N Engl J Med. 2016 Sep 29;375(13):1221-30. doi: 10.1056/NEJMoa1608029. Epub 2016 Aug 27.
5
Native T1 and T2 mapping by CMR in lupus myocarditis: Disease recognition and response to treatment.狼疮性心肌炎中通过心脏磁共振成像进行的固有T1和T2映射:疾病识别及对治疗的反应
Int J Cardiol. 2016 Nov 1;222:717-726. doi: 10.1016/j.ijcard.2016.07.182. Epub 2016 Aug 3.
6
Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis.心脏结节病患者心肌瘢痕在心脏磁共振成像中的预后价值
JACC Cardiovasc Imaging. 2017 Apr;10(4):411-420. doi: 10.1016/j.jcmg.2016.05.009. Epub 2016 Jul 20.
7
Prognostic Value of LGE-CMR in HCM: A Meta-Analysis.LGE-CMR 在 HCM 中的预后价值:一项荟萃分析。
JACC Cardiovasc Imaging. 2016 Dec;9(12):1392-1402. doi: 10.1016/j.jcmg.2016.02.031. Epub 2016 Jul 20.
8
Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use.风湿病学中的心血管磁共振成像:现状与应用建议
Int J Cardiol. 2016 Aug 15;217:135-48. doi: 10.1016/j.ijcard.2016.04.158. Epub 2016 Apr 27.
9
Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach.采用心血管磁共振成像与血浆分析相结合的方法,鉴定肌营养不良患者中与心肌病相关的循环miRNA生物标志物。
J Cardiovasc Magn Reson. 2016 May 6;18(1):25. doi: 10.1186/s12968-016-0244-3.
10
Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.肥厚型心肌病患者心脏磁共振成像显示的弥漫性心室纤维化与室性心动过速相关。
J Cardiovasc Electrophysiol. 2016 May;27(5):571-80. doi: 10.1111/jce.12948. Epub 2016 Mar 14.